Page last updated: 2024-10-17

aminocaproic acid and Diabetes Mellitus, Adult-Onset

aminocaproic acid has been researched along with Diabetes Mellitus, Adult-Onset in 2 studies

Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
McIntyre, EA1
Halse, R1
Yeaman, SJ1
Walker, M1
Doyle, ME1
Greig, NH1
Holloway, HW1
Betkey, JA1
Bernier, M1
Egan, JM1

Other Studies

2 other studies available for aminocaproic acid and Diabetes Mellitus, Adult-Onset

ArticleYear
Cultured muscle cells from insulin-resistant type 2 diabetes patients have impaired insulin, but normal 5-amino-4-imidazolecarboxamide riboside-stimulated, glucose uptake.
    The Journal of clinical endocrinology and metabolism, 2004, Volume: 89, Issue:7

    Topics: Aged; Aminocaproic Acid; Cells, Cultured; Diabetes Mellitus, Type 2; Female; Glucose; Glycogen; Glyc

2004
Insertion of an N-terminal 6-aminohexanoic acid after the 7 amino acid position of glucagon-like peptide-1 produces a long-acting hypoglycemic agent.
    Endocrinology, 2001, Volume: 142, Issue:10

    Topics: Amino Acid Sequence; Aminocaproic Acid; Animals; Cell Line; Diabetes Mellitus, Type 2; Glucagon; Glu

2001